MWNA
BPMC
Marshall Wace North America’s Blueprint Medicines BPMC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | $42.1M | Buy |
409,205
+386,792
| +1,726% | +$39.8M | 0.18% | 124 |
|
2021
Q2 | $1.97M | Buy |
+22,413
| New | +$1.97M | 0.01% | 793 |
|
2021
Q1 | – | Sell |
-4,970
| Closed | -$557K | – | 1478 |
|
2020
Q4 | $557K | Buy |
+4,970
| New | +$557K | ﹤0.01% | 1066 |
|
2020
Q3 | – | Sell |
-11,481
| Closed | -$896K | – | 1222 |
|
2020
Q2 | $896K | Sell |
11,481
-24,545
| -68% | -$1.92M | 0.01% | 786 |
|
2020
Q1 | $2.11M | Buy |
+36,026
| New | +$2.11M | 0.02% | 470 |
|
2019
Q2 | – | Sell |
-263,648
| Closed | -$21.1M | – | 1184 |
|
2019
Q1 | $21.1M | Buy |
+263,648
| New | +$21.1M | 0.15% | 139 |
|
2018
Q4 | – | Sell |
-29,868
| Closed | -$2.33M | – | 1478 |
|
2018
Q3 | $2.33M | Buy |
+29,868
| New | +$2.33M | 0.02% | 463 |
|
2017
Q3 | – | Sell |
-24,515
| Closed | -$1.25M | – | 1266 |
|
2017
Q2 | $1.25M | Buy |
24,515
+9,582
| +64% | +$489K | 0.01% | 866 |
|
2017
Q1 | $597K | Buy |
+14,933
| New | +$597K | ﹤0.01% | 791 |
|